Natalie Armstrong, the Head of Marketing at Sandoz Australia and New Zealand, said, “The PBS listing of JUBBONTI and WYOST marks a pivotal moment for healthcare sustainability in Australia. By introducing competition into a high-cost therapy area, we’re working to reduce the burden on the PBS."
Sandoz biosimilars of major osteoporosis therapy available via the PBS
August 1, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Company size shapes CEO pay trends in Australian health care and biotechnology
October 6, 2026 - - Latest News -
Young NZ cancer patients to get funded medicines no matter where they are treated
October 6, 2026 - - Latest News -
TGA turns to national security surveillance platform to police therapeutic goods compliance
October 6, 2026 - - Latest News -
CSL announces investment for share of Alentis rare kidney and liver candidate
October 6, 2026 - - Latest News -
TGA approves Roche's refillable eye implant for wet macular degeneration
October 5, 2026 - - Latest News -
The 'Dispatched' Podcast Week in Review - Series 5. Ep.34
October 2, 2026 - - Podcast -
Under the TGA's new rules, the safest story is one without the patient experience
October 2, 2026 - - Latest News
